{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T22:06:34Z","timestamp":1785017194188,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007405","name":"Hjerteforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ijcha.2019.100370","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:04:40Z","timestamp":1559217880000},"page":"100370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction"],"prefix":"10.1016","volume":"24","author":[{"given":"Jakob","family":"Schroder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naja Dam","family":"Mygind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Frestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah Elena","family":"Suhrs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira Bang","family":"Bove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kastrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijcha.2019.100370_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003064","article-title":"Coronary microvascular function and cardiovascular risk factors in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study","volume":"5","author":"Mygind","year":"2015","journal-title":"J. Am. Heart Assoc."},{"issue":"11","key":"10.1016\/j.ijcha.2019.100370_bb0010","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","article-title":"Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade","volume":"135","author":"Noel Bairey Merz","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.ijcha.2019.100370_bb0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.atherosclerosis.2018.06.864","article-title":"Protein biomarkers and coronary microvascular dilatation assessed by rubidium-82 PET in women with angina pectoris and no obstructive coronary artery disease","volume":"275","author":"Schroder","year":"2018","journal-title":"Atherosclerosis."},{"issue":"4","key":"10.1016\/j.ijcha.2019.100370_bb0020","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ahj.2014.01.003","article-title":"Improving diagnosis and treatment of women with angina pectoris and microvascular disease: the iPOWER study design and rationale","volume":"167","author":"Prescott","year":"2014","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.ijcha.2019.100370_bb0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ejechocard\/jen175","article-title":"Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC)","volume":"9","author":"Sicari","year":"2008","journal-title":"Eur. J. Echocardiogr."},{"issue":"4","key":"10.1016\/j.ijcha.2019.100370_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcha.2019.100370_bb0035","series-title":"Biostatistics: The Bare Essentials","author":"Norman","year":"2009"},{"issue":"2","key":"10.1016\/j.ijcha.2019.100370_bb0040","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/2047487312437713","article-title":"Exploring clinical predictors of cardiovascular disease in a central Australian aboriginal cohort","volume":"20","author":"Luke","year":"2013","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"15","key":"10.1016\/j.ijcha.2019.100370_bb0045","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1161\/01.CIR.0000161957.34198.2B","article-title":"Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth","volume":"111","author":"Goodman","year":"2005","journal-title":"Circulation."},{"issue":"7","key":"10.1016\/j.ijcha.2019.100370_bb0050","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.drudis.2017.01.005","article-title":"The application of principal component analysis to drug discovery and biomedical data","volume":"22","author":"Giuliani","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijcha.2019.100370_bb0055","series-title":"Psychometric Theory. Vol. 3","first-page":"701","author":"Nunnally","year":"1994"},{"key":"10.1016\/j.ijcha.2019.100370_bb0060","unstructured":"Stevens JP. Applied multivariate statistics for the social sciences. Routledge. 2009.663 p."},{"issue":"6","key":"10.1016\/j.ijcha.2019.100370_bb0065","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jcmg.2012.12.011","article-title":"Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease","volume":"6","author":"Recio-Mayoral","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"4","key":"10.1016\/j.ijcha.2019.100370_bb0070","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.numecd.2013.09.021","article-title":"Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease","volume":"24","author":"Tona","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"3","key":"10.1016\/j.ijcha.2019.100370_bb0075","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/en.2013-1772","article-title":"CCL2-dependent macrophage recruitment is critical for mineralocorticoid receptor-mediated cardiac fibrosis, inflammation, and blood pressure responses in male mice","volume":"155","author":"Shen","year":"2014","journal-title":"Endocrinology."},{"issue":"1","key":"10.1016\/j.ijcha.2019.100370_bb0080","first-page":"773","article-title":"Correlations of chemokine CXCL16 and TNF-\u03b1 with coronary atherosclerotic heart disease","volume":"15","author":"Xing","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.ijcha.2019.100370_bb0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/cvr\/cvn071","article-title":"High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: Down-regulatory effects of statins","volume":"79","author":"Smith","year":"2008","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.ijcha.2019.100370_bb0090","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/01.ATV.0000124102.11472.36","article-title":"CXCL16\/SR-PSOX is an interferon-\u03b3-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions","volume":"24","author":"Wuttge","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.ijcha.2019.100370_bb0095","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1128\/IAI.68.7.3965-3970.2000","article-title":"Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model","volume":"68","author":"Wang","year":"2000","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.ijcha.2019.100370_bb0100","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.atherosclerosis.2008.07.015","article-title":"The association between peptidoglycan recognition protein-1 and coronary and peripheral atherosclerosis: observations from the Dallas Heart Study","volume":"203","author":"Rohatgi","year":"2009","journal-title":"Atherosclerosis."},{"issue":"6","key":"10.1016\/j.ijcha.2019.100370_bb0105","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.cellsig.2012.02.006","article-title":"Signal transduction by tumor necrosis factor receptors","volume":"24","author":"Cabal-Hierro","year":"2012","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.ijcha.2019.100370_bb0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pharmthera.2010.05.002","article-title":"TNF\u03b1 in atherosclerosis, myocardial ischemia\/reperfusion and heart failure","volume":"127","author":"Kleinbongard","year":"2010","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ijcha.2019.100370_bb0115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/eurjhf\/hft125","article-title":"Inflammatory cytokines in chronic heart failure: Interleukin-8 is associated with adverse outcome. Results from CORONA","volume":"16","author":"Nymo","year":"2014","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcha.2019.100370_bb0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to Interleukin-6 to Interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ. Res."},{"issue":"27","key":"10.1016\/j.ijcha.2019.100370_bb0125","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","article-title":"Anti-inflammatory therapies for cardiovascular disease","volume":"35","author":"Ridker","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2019.100370_bb0130","doi-asserted-by":"crossref","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017; NEJMoa1707914.","DOI":"10.1056\/NEJMoa1707914"},{"key":"10.1016\/j.ijcha.2019.100370_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2474-11-192","article-title":"TRAIL death receptor-4, decoy receptor-1 and decoy receptor-2 expression on CD8+ T cells correlate with the disease severity in patients with rheumatoid arthritis","volume":"11","author":"Bisgin","year":"2010","journal-title":"BMC Musculoskelet. Disord."},{"issue":"1","key":"10.1016\/j.ijcha.2019.100370_bb0140","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1373\/clinchem.2016.255174","article-title":"Growth differentiation factor 15 as a biomarker in cardiovascular disease","volume":"63","author":"Wollert","year":"2017","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.ijcha.2019.100370_bb0145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1373\/clinchem.2016.260570","article-title":"Growth differentiation factor 15 predicts all-cause morbidity and mortality in stable coronary heart disease","volume":"63","author":"Hagstr\u00f6m","year":"2017","journal-title":"Clin. Chem."},{"issue":"16","key":"10.1016\/j.ijcha.2019.100370_bb0150","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/eurheartj\/ehv491","article-title":"Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study","volume":"37","author":"Hagstr\u00f6m","year":"2016","journal-title":"Eur. Heart J."},{"issue":"23","key":"10.1016\/j.ijcha.2019.100370_bb0155","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1161\/01.CIR.0000038705.69871.D9","article-title":"Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction","volume":"106","author":"Weinberg","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.ijcha.2019.100370_bb0160","doi-asserted-by":"crossref","unstructured":"Seki K, Sanada S, Kudinova AY, Steinhauser ML, Handa V, Gannon J, et al. Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling. Circ Hear Fail. 2009; nov (6): 684\u201391.","DOI":"10.1161\/CIRCHEARTFAILURE.109.873240"},{"issue":"3","key":"10.1016\/j.ijcha.2019.100370_bb0165","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1373\/clinchem.2013.209858","article-title":"Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the ludwigshafen risk and cardiovascular health study","volume":"60","author":"Dieplinger","year":"2014","journal-title":"Clin. Chem."},{"issue":"7","key":"10.1016\/j.ijcha.2019.100370_bb0170","doi-asserted-by":"crossref","first-page":"48B","DOI":"10.1016\/j.amjcard.2015.01.041","article-title":"ST2 in stable and unstable ischemic heart diseases","volume":"115","author":"Richards","year":"2015","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcha.2019.100370_bb0175","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ijcard.2012.03.040","article-title":"CRP and suPAR are differently related to anthropometry and subclinical organ damage","volume":"167","author":"Lyngb\u00e6k","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2019.100370_bb0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2014.12.025","article-title":"Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease","volume":"239","author":"Mekonnen","year":"2015","journal-title":"Atherosclerosis."},{"issue":"5","key":"10.1016\/j.ijcha.2019.100370_bb0185","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001118","article-title":"Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events","volume":"3","author":"Eapen","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcha.2019.100370_bb0190","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation."},{"issue":"12","key":"10.1016\/j.ijcha.2019.100370_bb0195","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1042\/CS20180306","article-title":"Atherosclerosis and inflammation: overview and updates","volume":"132","author":"Geovanini","year":"2018","journal-title":"Clin. Sci."},{"issue":"3088","key":"10.1016\/j.ijcha.2019.100370_bb0200","first-page":"788","article-title":"Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate risk individuals. The multi-ethnic study of atherosclerosis","volume":"229624","author":"Yeboah","year":"2012","journal-title":"JAMA August."},{"issue":"5","key":"10.1016\/j.ijcha.2019.100370_bb0205","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2217\/fca.15.39","article-title":"Novel biomarkers for cardiovascular risk assessment: current status and future directions","volume":"11","author":"Macnamara","year":"2015","journal-title":"Futur. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcha.2019.100370_bb0210","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/HCO.0b013e3282f43039","article-title":"Biomarkers in heart failure management","volume":"23","author":"Braunwal","year":"2008","journal-title":"Curr. Opin. Cardiol."},{"issue":"23","key":"10.1016\/j.ijcha.2019.100370_bb0215","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/01.CIR.0000129318.79570.84","article-title":"Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham heart study","volume":"109","author":"Sundstr\u00f6m","year":"2004","journal-title":"Circulation."},{"issue":"12","key":"10.1016\/j.ijcha.2019.100370_bb0220","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","article-title":"Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease","volume":"107","author":"Blankenberg","year":"2003","journal-title":"Circulation."},{"issue":"3","key":"10.1016\/j.ijcha.2019.100370_bb0225","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/eurheartj\/eht420","article-title":"Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial","volume":"35","author":"Cerisano","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2019.100370_bb0230","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.atherosclerosis.2016.08.026","article-title":"Circulating progenitor cells and coronary microvascular dysfunction: results from the NHLBI-sponsored Women's ischemia syndrome evaluation\u2013coronary vascular dysfunction study (WISE-CVD)","volume":"253","author":"Mekonnen","year":"2016","journal-title":"Atherosclerosis."},{"issue":"1","key":"10.1016\/j.ijcha.2019.100370_bb0235","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.atherosclerosis.2014.09.014","article-title":"Serum concentrations of galectin-3 in patients with cardiac syndrome X","volume":"237","author":"Bozcali","year":"2014","journal-title":"Atherosclerosis."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906719300685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906719300685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:07:30Z","timestamp":1762492050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906719300685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":47,"alternative-id":["S2352906719300685"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2019.100370","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2019.100370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100370"}}